Aurinia Pharmaceuticals Inc. (AUPH) has a market capitalization of $2.14B and trades at $16.07. The 52-week range is 6.825-16.54.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of 7.5, Earnings Per Share (EPS) of $2.14, annual revenue of $283.06M.
The stock has a beta of 1.52, operates in the Healthcare sector.
